Based on this finding, we also hypothesized that the calorie-restricted ketogenic diet (KD) would mimic the effects of GLUT1 inhibitors and reduce glucose uptake by cancer cells and would further enhance the anticancer effect of OXPHOS inhibitors. The gene discussed is SLC2A1; the disease is cancer.